Spectrum Pharmaceuticals to Be Added to the S&P SmallCap 600 Index

Spectrum Pharmaceuticals SPPI today announced that the company has been selected to be added to the S&P SmallCap 600® Index at the close of trading on Tuesday, April 24, 2012. Following this addition, the Company will be a component of the NASDAQ Biotechnology Index®, the Russell 3000®, Russell 2000®, Russell Global® and S&P SmallCap 600® indices.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!